Vitable Health vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Philadelphia employer primary care for blue-collar SMB workforces at $30/employee/month with in-home visits; YC-backed $25M with $16M Cherryrock Series A competing with Amazon One Medical for hourly worker healthcare.
About
Vitable Health is a Philadelphia-based healthcare technology company delivering in-home and virtual primary care services to small and mid-sized businesses with blue-collar and hourly workforces — providing comprehensive medical care including prescriptions, lab tests, mental health services, and care navigation at approximately $30 per employee per month, significantly below the cost of traditional employer health insurance. Founded in 2019 and backed by Y Combinator with $25 million raised including a $16 million Series A in July 2024 led by Cherryrock Capital, Vitable serves SMBs with workforces in logistics, construction, manufacturing, and home services that are systematically underserved by traditional employer benefits.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.